Post Thrombotic Syndrome Clinical Trial
Official title:
A Randomized Trial to Determine the Impact of Lymphedema Therapy on Quality of Life and Disease Severity in Patients With Post-Thrombotic Syndrome
The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.
Post thrombotic syndrome (PTS) has a spectrum of disease manifestations ranging from minor
skin discoloration to severe skin changes and venous ulcerations. Pain is often a prominent
symptoms and PTS impairs patient quality of life. Prevention of PTS using compression
stockings has been emphasized. There is a paucity of validated, effective treatments for PTS
once the condition develops.
While the pathophysiology of PTS is incompletely understood, chronic venous hypertension and
insufficiency may increase the workload of the lymphatic system and result in
over-capacitance with secondary damage and eventual lymphatic insufficiency. In selected
patients with PTS, we have noted a symptomatic improvement in patients who receive lymphedema
therapy to the limb.
Complex lymphedema therapy (CLT) is a noninvasive treatment that includes four key
components: meticulous skin care, manual lymph drainage, compression therapy, exercises and
patient education for home management and continuation of the treatment. These techniques are
designed to enhance lymph flow through intact cutaneous lymphatics and reduce swelling and
restore function in the affected limb.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05744843 -
Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome
|
N/A | |
Recruiting |
NCT05622500 -
Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease
|
N/A | |
Recruiting |
NCT05296499 -
EXERT: Exercise Physiology After Thrombosis
|
||
Recruiting |
NCT04250025 -
Angioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction
|
N/A | |
Completed |
NCT00790335 -
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
|
Phase 3 | |
Completed |
NCT03075761 -
Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)
|
N/A | |
Terminated |
NCT04794569 -
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
|
Phase 4 | |
Recruiting |
NCT03368313 -
Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis
|
N/A | |
Terminated |
NCT04103112 -
Compression Hosiery to Avoid Post-Thrombotic Syndrome
|
N/A | |
Completed |
NCT00858130 -
Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)
|
N/A | |
Recruiting |
NCT06046807 -
Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).
|
||
Not yet recruiting |
NCT01637428 -
The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome
|
Phase 2 | |
Recruiting |
NCT03250247 -
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
|
N/A | |
Completed |
NCT03054727 -
Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )
|
||
Completed |
NCT04825548 -
Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol
|
||
Withdrawn |
NCT03039517 -
Post Thrombotic Syndrome Prevention Study
|
N/A | |
Recruiting |
NCT02268630 -
Long Term Outcomes of Venous Thromboembolism
|
N/A | |
Completed |
NCT03757481 -
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE
|
N/A | |
Recruiting |
NCT04319627 -
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
|
Phase 3 | |
Withdrawn |
NCT04411316 -
Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis
|
Phase 4 |